Owkin

🤖 Introducing Owkin K: A community of specialized AI agents. Their mission? To work with our data scientists on decoding the complexities of the immune system. We are excited to continue our ambition for the future of drug discovery, development and diagnostics. 🚀 Watch the video to find out how Owkin will use agentic AI in the future. #ai #agenticai

🏖️ Celebrating the second installment of our #OwkinSummer series. Last week, our Chief R&D Officer, Jean-Philippe Vert, returned to Mbour to teach at the African Institute for Mathematical Sciences Sénégal in the African Masters in Machine Intelligence (AMMI) program. This groundbreaking graduate program offers exceptional young Africans cutting-edge courses on machine learning and its applications. 🚀👾

Check out the latest from Owkin in July 🌐 📰 Catch up on our top highlights of the month from Owkinews. From groundbreaking healthcare innovations to cutting-edge research, we've got it all. 📬 Stay informed! Subscribe to join us on our journey of healthcare innovation.

With its ability to analyze vast amounts of structured data to characterize targets, there is no doubt that AI has been transforming the drug discovery landscape. At Owkin, we developed an LLM tool that obtains biological summaries of specific genes instantaneously and integrated it into our “biologist-in-the-loop model” to augment human expertise. Ultimately, this will help us accelerate the pace of discovery through our AI drug discovery engine, TargetMATCH. 📕 Read more about our “biologist-in-the-loop model”: https://lnkd.in/eQxRz2qi #AI #LLMs #drugdiscovery

Identify the best patients for your drug with Owkin Dx 🎯 Genetic testing can take days, if not weeks. But with Owkin Dx, our AI can predict genetic mutations from routine histology slides in minutes. Our scalable and tissue-sparing solution accelerates drug trials and identifies the right patients faster. Schedule a demo to learn more: https://lnkd.in/g3CBMVfr

Earlier this month, we attended the International Spatial Biology Congress 2024, where the significance of spatial biology in drug discovery and development was a key focus. In our latest blog, we provide an overview of the discussions, highlighting the opportunities that spatial biology offers in modern drug discovery and development, as well as addressing the challenges and future directions for the field. 📕 Read the blog at https://lnkd.in/eRkcxD4R #spatialomics #drugdiscovery

🏖️ Summer is in full swing, and we couldn’t be happier. To celebrate these sun-soaked months, we’re excited to share our Owkinautes' summer adventures. They're off on exciting journeys around the world, and we're eager to follow along! In two weeks, our Chief Marketing Officer, Darius Meadon, will head to Bali to complete his 200-hour Yoga Teacher Training. He plans to use his new skills to start community yoga classes in London for people with mental health issues, those recovering from injury and long term illness, and older/vulnerable people affected by isolation. ���💛 #OwkinSummer

Today, our latest machine learning (ML) research on the application of representation learning to RNA-seq data was published in Nature Scientific Reports. Using pan-cancer datasets (TCGA and DepMap), we assessed various models for their power to predict survival and gene essentiality, and explored the impact of various ML design choices, on the performance of the learned representations. 📕 Check out our open access publication to learn more about the results of this research: https://lnkd.in/ebp9XV72 #AI #representationlearning #RNAseq #cancerresearch

We are excited to share our latest research introducing our new AI model, MISO (Multiscale Integration of Spatial Omics), available today as a preprint on bioRxiv & medRxiv. Trained on a new unpublished dataset of 72 10X Genomics Visium samples with corresponding digital pathology images, MISO enables near single-cell-resolution, spatially-resolved gene expression prediction from H&E-stained slides. With spatial transcriptomics remaining challenging to use routinely, our model represents a novel approach for augmenting multimodal datasets and scale up integration of spatial transcriptomics data with tumor morphology. 📑 Read our pre-print at https://lnkd.in/gsvdKk7p #AI #spatialomics

Accelerate oncology breakthroughs and improve patient outcomes with the world's largest spatial omics dataset for oncology, MOSAIC research 🧬 We’re harnessing the power of AI and spatial omics to assist oncologists and pathologists in advancing drug discovery and enhancing target identification. Schedule your demo here to learn more: https://lnkd.in/ecMupPaf